Data Page

The global Pharmaceutical contract manufacturing industry has registered strong growth during the past few years. The outsourcing of drugs manufacturing provides many advantages to the Pharmaceutical companies, such as improved production capacity, quicker time to market drugs, and low scale up cost. Cian, through contract manufacturing helps other Pharmaceutical companies to meet their growing demands for new drugs and improve their core competencies.

In India Cian has superior edge over other third party manufacturing companies and having State of Art, WHO-GMP, ISO 9001-2015 plant certified plant. Contract manufacturing is growing at CAGR of greater than 30 percent. We have strong 300 plus clients for third party manufacturing.

We have reputed clients in third party namely Cadila, Veritaz Healthcare Ltd., Meyer organic Pvt Ltd., Wallace pharmaceuticals, Apollo Hospitals Enterprises Ltd., Sava Healthcare Limited, Helios solutions, Wiscon Pharmaceuticals Pvt. Ltd., Lyka Healthcare.

We offer unique benefits like:
Availability of adequate, compliant facilities for almost all dosage forms.
Availability of licences and development of products as per the market requirements. We have special license for Veterinary products. We are developing these segments as our future business plan. We have approval of 18 plus Unique Veterinary products and our eminent clients are Sava vet and Venky’s and many more.

We have more than 500 brands for various Therapeutic segments which are available in the market trough our 300 plus strong franchisee distributors. This business model is going to grow because of our unique as well as patent (applied) formulations. We are making brand plan as well as unique customer centric strategies for our franchisee distributors which are our key customers and market Penetrators. 10 division are catering twelve Therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals.

Continuous addition of innovative brands and DCGI approved products as well as first time in India products will provide faster growth in competitive market.

Scroll to Top